Skip to main content
OpenTrials
Completed

NCT Number: NCT04492384

Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients

Non-commercial depersonalized multi-centered registry study on analysis of chronic non-infectious diseases dynamics after SARS-CoV-2 infection in adults.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Covid19 Body Weight CKD COPD COVID-19 Cardiac Event Cardiovascular Diseases Chronic Disease Coronary Disease Coronary Heart Disease Coronaviridae Infections Coronavirus Infections Diabetes Diabetes Mellitus Disease Attributes Endocrine System Diseases Glucose Metabolism Disorders Heart Diseases Hypertension Infections Lung Diseases Lung Diseases, Obstructive Metabolic Diseases Myocardial Ischemia Nidovirales Infections Nutrition Disorders Nutritional and Metabolic Diseases Obesity Overnutrition Overweight Overweight and Obesity Pathologic Processes Pathological Conditions, Signs and Symptoms Pneumonia Pneumonia, Viral Pulmonary Disease, Chronic Obstructive RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Sars-CoV-2 Infection Signs and Symptoms Vascular Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Eurasian Association of Therapists

Moscow, 101000, Russia

About this study

Non-commercial depersonalized multi-centered registry study on analysis of chronic non-infectious diseases dynamics after SARS-CoV-2 infection in cohort of Russian adult patients.

Retrospective analysis of medical histories and outcomes in adults with pre-existing conditions after SARS-CoV-2 infection and prospective monitoring of health status during 3, 6 and 12 months after discharge. Comorbidities worsening risk factors measuring through evaluation of range of indicators such as dynamics of diabetes, CKD, COPD, bronchial astma, incidence of hypertonic crises, vascular events and others.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Suspected or confirmed COVID-19.

Exclusion criteria

  • Refuse to be involved in study;
  • Age under 18 years.

Treatment and study plan

Non-Interventional

Other

Interview on health conditions

Primary outcomes

  1. rate of non-infectious diseases

    Time frame: 12 month since a moment of request of medical help

    percentage of patients with non-infectious diseases relating to overall number of patients registered in study

  2. severity of COVID-19 depending on pre-existing diseases

    Time frame: 12 month since a moment of request of medical help

    correlation between number of patients with COVID-19 of various severity and number of pre-existing conditions and their severity among these groups

  3. disability registration / change of disability status

    Time frame: 12 month since a moment of request of medical help

    Registration of disability or change of disability status

  4. rate of letal outcomes

    Time frame: 12 month since a moment of request of medical help

    rate of deaths among registered participants

  5. rate of letal outcomes depending on pre-existing disease

    Time frame: 12 month since a moment of request of medical help

    correlation between number of deaths and pre-existing diseases

Sponsors and collaborators

Lead sponsor

Eurasian Association of Therapists

Other

Registry information

Acronym: ACTIV

Important dates

Study start
2020
Primary completion
2020
Study completion
2021
First posted
Jul 30, 2020
Registry last updated
Sep 8, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.